CME Outfitters is pleased to provide accredited medical education on the clinical management of multiple sclerosis (MS).You can earn credit with online activities that fit your schedule and educational requirements. In the on-demand webcasts and podcasts listed below, you’ll hear from experts about cutting-edge research findings, newly approved disease-modifying therapies (DMTs) for both relapsing and progressive MS, the latest biomarker and imaging techniques for diagnosis and management of MS, innovative care practices, and health policy issues affecting access to care. Our experts translate the latest scientific data into practical education that will enable you to provide the best possible care for your patients with MS.
In this CME Outfitters Live and OnDemand webcast, animated 3-D models will illustrate the immune processes that contribute to MS pathology and serve as targets for immune-directed therapies.
In this CMEOCast podcast, expert faculty discuss treatment initiation options, particularly high efficacy treatments versus escalation, as well as when switching therapies might be necessary and how to take patient- and medication-related issues into consideration.
This CMEOCast podcast focuses on treating patients with MS in accordance with current guidelines, including evaluating and assessing COVID-19 disease severity and individualizing therapeutic strategy based on patient, disease, and drug factors.
This video is a replay of a plenary session from the 12th Annual Chair Summit Master Class for Neuroscience Professional Development held in Las Vegas, NV from February 27 – 29, 2020.
This CME Outfitters On Demand webcast will include an interactive, case-based panel discussion featuring expert faculty who will discuss the symptoms and clinical features of progressive MS, summarize its immunopathology and the mechanisms of action (MOAs) of new and investigational disease modifying therapies (DMTs), and evaluate the latest clinical evidence on the efficacy and safety of new and emerging therapies for SPMS and PPMS.
In this CME Outfitters virtual symposium, expert faculty will focus on the prognostic factors that should be considered when developing treatment plans for patients with MS, as well as the latest clinical data on approved and emerging DMTs, so that clinicians can confidently develop tailored treatment approaches based on individual patient characteristics and appropriately monitor treatment response, safety, and tolerability.